JPRN-UMIN000026976
Recruiting
未知
Clinical Outcome of Multicatheter Brachytherapy APBI in breast-conserving Therapy (COMBAT) for breast cancer patients after neoadjuvant chemotherapy - COMBAT-NEO
Tokyo-West Tokushukai Hospital0 sites30 target enrollmentApril 13, 2017
ConditionsBreast Cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Breast Cancer
- Sponsor
- Tokyo-West Tokushukai Hospital
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Mastectomy 2\. Recurrent disease 3\. Paget disease 4\. Connective tissue disease 5\. Pregnancy 6\. Inappropriate cases judged by investigators
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Clinical Outcome of Multicatheter Brachytherapy APBI in breast-conserving Therapy (COMBAT)for breast cancer patients-A(adjuvant),-C(complications and cosmesis)breast cancerJPRN-UMIN000029907Tokyo-West Tokushukai Hospital Breast oncology center850
Completed
Not Applicable
Multicatheter interstitial brachytherapy (MIBT) based accelerated partial breast irradiation (APBI) - dosimetric comparison with external beam radiotherapy and report on early outcomes in terms of toxicity and local controlHealth Condition 1: null- Post Surgery For Breast CancerCTRI/2018/01/011300ot Applicable21
Completed
Not Applicable
Intraluminal brachytherapy treatment results analysis of unresectable recurrent cholangiocarcinomaNeoplasmsKCT0000738Chonbuk National University Hospital30
Completed
Phase 3
RCT of Tri-Modalities with I-125 Brachy Therapy and EBRT and Short or Long Term Hormone Therapy for High-risk Localized Prostate CancerProstate CancerJPRN-UMIN000003992Kanazawa University Translational Research Informatices Center340
Completed
Phase 1
A phase I/II study of hybrid brachytherapy for locally advanced cervical carcinomaJPRN-jRCTs031180250Igaki Hiroshi55